Assessment of CymActive™ Catheter Technology for UrinAry ReTention and AcceptancE (The ACCTUATE Study)

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 29, 2025

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions
Urinary Retention
Interventions
DEVICE

cymactive™ catheter device (CCD)

"The cymactive™ catheter (manufactured by Ingenion Medical Ltd) received CE marking on the 28th March 2024, as a Class IIb device (n. ECM24MDR002 rev.0, Single Registration Number (SRN) of the Manufacturer UK-MF-000041065) and will be available in the UK market, subject to local arrangements.~The cymactive™ catheter is designed to remain in situ for up to 30 days, does not extend outside the patient's body except for 2 removal strings, and has an integral, magnetically controlled valve that allows the user to control their own urination. The study participant will each be supplied with a magnetic Actuator (a separate Class I device supplied by Ingenion Medical) so they are in control of valve and their own voiding. The magnet is strong and care will need to be taken to keep it at least 6 inches from magnetically-sensitive items, i.e. mobile phones, laptops and credit cards. Study participants should also avoid contact with MRI machines."

DEVICE

Foley-type catheter device

Routine standard of care. Usually replaced \~ 3 monthly

Trial Locations (5)

CB2 0QQ

RECRUITING

Addenbrookes Hospital - Cambridge University Hospitals NHS Foundation Trust, Cambridge

EX2 5DW

RECRUITING

Royal Devon & Exeter Hospital - Royal Devon University Healthcare NHS Trust, Exeter

IP4 5PD

RECRUITING

Ipswich Hospital - East Suffolk and North Essex NHS Foundation Trust, Ipswich

GU16 7UJ

RECRUITING

Frimley Park Hospital - Frimley Health NHS Foundation Trust, Camberley

BS10 5NB

RECRUITING

Southmead Hospital - North Bristol NHS Trust,, Bristol

All Listed Sponsors
lead

Ingenion Medical Limited

INDUSTRY

NCT05848037 - Assessment of CymActive™ Catheter Technology for UrinAry ReTention and AcceptancE (The ACCTUATE Study) | Biotech Hunter | Biotech Hunter